Healthcare provider profile · identity verified

Thorley E. Cook, D.O.

Internal Medicine · FRANKLIN, MA · NPI 1841221876

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	610	174
Levothyroxine Sodium	Levothyroxine Sodium	454	130
Lisinopril	Lisinopril	399	121
Simvastatin	Simvastatin	263	68
Omeprazole	Omeprazole	233	67
Amlodipine Besylate	Amlodipine Besylate	213	65
Gabapentin	Gabapentin	177	52
Metformin Hcl	Metformin Hcl	173	51
Hydrochlorothiazide	Hydrochlorothiazide	166	50
Rosuvastatin Calcium	Rosuvastatin Calcium	153	45
Metoprolol Succinate	Metoprolol Succinate	126	37
Losartan Potassium	Losartan Potassium	123	39
Furosemide	Furosemide	116	33
Escitalopram Oxalate	Escitalopram Oxalate	110	38
Sertraline Hcl	Sertraline Hcl	108	32
Atenolol	Atenolol	101	31
Eliquis	Apixaban	97	17
Lorazepam	Lorazepam	96	27
Fluoxetine Hcl	Fluoxetine Hcl	91	22
Trazodone Hcl	Trazodone Hcl	91	31
Clonazepam	Clonazepam	87	13
Metoprolol Tartrate	Metoprolol Tartrate	87	20
Alprazolam	Alprazolam	84	18
Oxycodone Hcl	Oxycodone Hcl	81	17
Pravastatin Sodium	Pravastatin Sodium	74	23
Pantoprazole Sodium	Pantoprazole Sodium	72	20
Albuterol Sulfate Hfa	Albuterol Sulfate	70	26
Zolpidem Tartrate	Zolpidem Tartrate	64	11
Alendronate Sodium	Alendronate Sodium	63	20
Valsartan	Valsartan	62	21
Famotidine	Famotidine	59	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	18
Diclofenac Sodium	Diclofenac Sodium	53	suppressed
Bupropion Xl	Bupropion Hcl	47	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	12
Paroxetine Hcl	Paroxetine Hcl	42	12
Glipizide Er	Glipizide	41	13
Fluticasone Propionate	Fluticasone Propionate	40	17
Ibuprofen	Ibuprofen	40	suppressed
Mirtazapine	Mirtazapine	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	12
Glipizide	Glipizide	36	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	11
Allopurinol	Allopurinol	35	11
Synthroid	Levothyroxine Sodium	35	suppressed
Tramadol Hcl	Tramadol Hcl	34	16
Meclizine Hcl	Meclizine Hcl	32	14
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Labetalol Hcl	Labetalol Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Naproxen	Naproxen	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Nystatin	Nystatin	23	13
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Ozempic	Semaglutide	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Diazepam	Diazepam	14	suppressed
Diclofenac Potassium	Diclofenac Potassium	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Finasteride	Finasteride	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Prednisone	Prednisone	13	12
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Verapamil Er	Verapamil Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error